概括
这篇文章已被撤回. 撤回通知表明,科学界不再认为原始出版物是有效或可靠的.
科学领域:
- 科学出版伦理学 出版伦理学
- 研究诚信研究诚信
背景情况:
- 撤销是正式的通知,表明已发表的科学工作是无效的.
- 它们是因为严重的缺陷,道德问题或不当行为而发行的.
研究的目的:
- 为了正式撤回DOI标识的物品: 10.1155/2022/5249910.
- 通知科学界公布的研究无效.
主要方法:
- 由期刊发出正式的撤回声明.
- 通知相关的索引服务和数据库.
主要成果:
- 这篇文章DOI: 10.1155/2022/5249910 正式撤回.
- 收回的文章的发现和结论不再被认为是有效的.
结论:
- 撤回支持科学文献的完整性.
- 研究人员应查阅撤回通知,以详细了解撤回原因.
相关概念视频
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
208
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
208
01:09GPCRs Regulate Adenylyl Cylase Activity
5.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K